Abbott Laboratories
ABTStock
$98.83−32.62%52W
Market Cap$172.47B
P/E26.44x
Div yield2.82%
Beta0.60
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-39.06%
Price vs S&P 500 (4W)0.72%
VGM Score42.99
Market Capitalization$172.47B
P/E Ratio (Annual)26.44x
Indicated Dividend Yield (Annual)2.82%
Earnings Surprise History
Q1 261.15est. 1.16
Q2 261.31est. 1.29
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.03
4.00
4.00
4.03
Industry Peers — Pharmaceuticals(563)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ABTAbbott Laboratories | C | C | D | $98.83 |
| LLYEli Lilly & Co. | D | B | B | $1169.17 |
| JNJJohnson & Johnson | D | C | B | $249.97 |
| ABBVABBVIE INC. | D | C | B | $254.39 |
| MRKMerck & Co., Inc. | C | C | B | $127.63 |
| NVSNovartis AG | C | C | C | $152.73 |
| NVONovo-Nordisk A/S | C | B | C | $51.48 |
| AZNAstraZeneca PLC | C | B | C | $169.29 |
| PFEPfizer Inc. | B | C | C | $25.14 |
| VRTXVertex Pharmaceuticals Inc | D | C | C | $486.03 |
| BMYBristol-Myers Squibb Co. | B | C | B | $60.51 |
About
Abbott is a diversified healthcare company with leading products in cardiovascular devices, diabetes care, diagnostics, and nutrition. The company manufactures pacemakers, defibrillators, continuous glucose monitors, diagnostic testing equipment, and infant nutritional products. Approximately 60% of sales come from international markets, providing significant geographic diversification.